» Articles » PMID: 29554474

Impaired Social Behaviors and Minimized Oxytocin Signaling of the Adult Mice Deficient in the N-methyl-d-aspartate Receptor GluN3A Subunit

Overview
Journal Exp Neurol
Specialty Neurology
Date 2018 Mar 20
PMID 29554474
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of neurological diseases, such as schizophrenia, autism spectrum disorders (ASD), and Alzheimer's disease (AD), whose unique clinical hallmark is a constellation of impaired social and/or cognitive behaviors. GluN3A (NR3A) is a unique inhibitory subunit in the NMDAR complex. The role of GluN3A in social behavioral activities is obscure. In this study, we sought to evaluate altered social activities in adult GluN3A knockout (KO) mice. GluN3A KO mice spent less time in reciprocal social interaction in the social interaction test compared to wild-type (WT) mice. A social approach test using a three-chamber system confirmed that mice lacking GluN3A had lower sociability and did not exhibit a preference for social novelty. GluN3A KO mice displayed abnormal food preference in the social transmission of food preference task and low social interaction activity in the five-trial social memory test, but without social memory deficits. Using a home cage monitoring system, we observed reduced social grooming behavior in GluN3A KO mice. Signaling genes that might mediate the altered social behaviors were examined in the prefrontal cortex, hippocampus, and thalamus. Among nine genes examined, the expression of the oxytocin receptor was significantly lower in the prefrontal cortex of GluN3A KO mice than that in WT mice. Oxytocin treatment rescued social activity deficits in GluN3A KO mice. These findings support a novel idea that a chronic state of moderate increases in NMDAR activities may lead to downregulation of the oxytocin signaling and impaired behavioral activities that are seen in psychiatric/neurodegenerative disorders.

Citing Articles

Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease.

Jin D, Zhang M, Shi L, Liu H Int J Neuropsychopharmacol. 2024; 28(1).

PMID: 39223908 PMC: 11781222. DOI: 10.1093/ijnp/pyae038.


Repetitive Transcranial Magnetic Stimulation-Mediated Neuroprotection in the 5xFAD Mouse Model of Alzheimer's Disease Through GABRG2 and SNAP25 Modulation.

Wang J, Zhou C, Huang Z, Ji X, Cui R, Kang Y Mol Neurobiol. 2024; 62(2):1971-1997.

PMID: 39052185 DOI: 10.1007/s12035-024-04354-7.


Challenges and advanced concepts for the assessment of learning and memory function in mice.

Lang B, Kahnau P, Hohlbaum K, Mieske P, Andresen N, Boon M Front Behav Neurosci. 2023; 17:1230082.

PMID: 37809039 PMC: 10551171. DOI: 10.3389/fnbeh.2023.1230082.


Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.

Yu S, Jiang M, Shim S, Pourkhodadad S, Wei L Mol Neurodegener. 2023; 18(1):43.

PMID: 37400870 PMC: 10318843. DOI: 10.1186/s13024-023-00636-1.


Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists.

Rouzbeh N, Rau A, Benton A, Yi F, Anderson C, Johns M J Gen Physiol. 2023; 155(6).

PMID: 37078900 PMC: 10125900. DOI: 10.1085/jgp.202313340.


References
1.
Simen B, Duman C, Simen A, Duman R . TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006; 59(9):775-85. DOI: 10.1016/j.biopsych.2005.10.013. View

2.
Akillioglu K, Binokay S, Kocahan S . The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice. Behav Brain Res. 2012; 233(1):157-61. DOI: 10.1016/j.bbr.2012.04.041. View

3.
Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View

4.
Harris L, Sharp T, Gartlon J, Jones D, Harrison P . Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci. 2003; 18(6):1706-10. DOI: 10.1046/j.1460-9568.2003.02902.x. View

5.
Bendel O, Prunell G, Stenqvist A, Mathiesen T, Holmin S, Svendgaard N . Experimental subarachnoid hemorrhage induces changes in the levels of hippocampal NMDA receptor subunit mRNA. Brain Res Mol Brain Res. 2005; 137(1-2):119-25. DOI: 10.1016/j.molbrainres.2005.02.023. View